Skip to content
Disclosery

Geneva Advisors, LLC: GMED position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Geneva Advisors, LLC on GMED, newest first. How the timeline and the estimate are built.

Geneva Advisors, LLC held 45,457 GMED shares at 2017-06-30 per its 13F-HR filed 2017-08-07.

the latest 13F is the newest step

  1. period ended2017-06-30
    13F 45,457 shares
    Change vs previous 13F +1,413 shares

    0.03% of the 13F portfolio, value $1,507,000.

    13F-HR 0001144204-17-040796 filed by Geneva Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2017-03-31
    13F 44,044 shares
    Change vs previous 13F +2,065 shares

    0.02% of the 13F portfolio, value $1,305,000.

    13F-HR 0001144204-17-023557 filed by Geneva Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2016-12-31
    13F 41,979 shares
    Change vs previous 13F -12,481 shares

    0.02% of the 13F portfolio, value $1,041,000.

    13F-HR 0001144204-17-007302 filed by Geneva Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2016-09-30
    13F 54,460 shares
    Change vs previous 13F not available

    0.02% of the 13F portfolio, value $1,229,000.

    13F-HR 0001144204-16-132719 filed by Geneva Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).